Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN111362962A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111362962A details a novel fluorinated norcantharidin derivative with enhanced anti-tumor activity. Discover scalable synthesis routes and supply chain advantages for pharmaceutical intermediates.